Skip to content
OpenCapital
Get started

Bruker BRKR Enterprise value

Enterprise value at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
$222.48B+0.9%
Danaher logo
DanaherDHR
$148.16B-8.7%
TEC
Bio-TechneTECH
$8.26B-13.6%
WAT
Waters CorporationWAT
$33.96B+48.0%
Agilent Technologies logo
Agilent TechnologiesA
$34.39B+5.1%
Revvity logo
RevvityRVTY
$12.88B-13.7%

Other financials

Income statement

See full
Revenue$823.4M+2.7%
Gross profit$379.8M-2.9%
Operating income$10.2M-67.9%
Net income$14.4M-17.2%
EPS (diluted)$0.02-81.8%

Balance sheet

See full
Cash & equivalents$137.6M-26.7%
Total debt$1.7B-20.9%
Total equity$2.5B+34.6%
Total assets$6.1B+3.3%

Cash flow

See full
Operating cash flow$71.2M+9.5%
CapEx$24.2M-6.9%
Free cash flow$47.0M+20.5%

Valuation

See full
Market cap$8.71B-13.2%
P/S2.5×-0.4×

Profitability

See full
Gross margin45.3%-3.7pp
Operating margin1.3%-5.0pp
Net margin-0.6%-10.0pp
FCF margin1.5%-3.6pp

Returns & leverage

See full
Return on equity-1%-21.2pp
Debt / equity0.7×-0.5×
Current ratio1.6×0.0×

Where this comes from

Calculated from Bruker’s reported figures.

$5.5Bmarket cap+$1.7Btotal debt−$137.6Mcash and equivalents=$7.03B

The official record: Bruker’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bruker's enterprise value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Bruker's enterprise value?
Bruker (BRKR) reported enterprise value of $7.03B in Q1 2026.
How has Bruker's enterprise value changed year-over-year?
Bruker's enterprise value decreased by 14.9% year-over-year, from $8.26B to $7.03B.
What is the long-term trend for Bruker's enterprise value?
Over 5 years (2020 to 2025), Bruker's enterprise value has grown at a 1.1% compound annual growth rate (CAGR), from $8.44B to $8.92B.
What does enterprise value mean?
What it would cost to buy the entire business, debt included and cash netted out.
How do you interpret enterprise value?
The capital-structure-neutral valuation base — used in EV/EBITDA and EV/Sales to compare companies with different leverage on a like-for-like footing.
How does enterprise value compare across companies?
Comparable across non-financial companies via the EV multiples it feeds; not used for banks and insurers.